Dynavax (DVAX) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts DVAX Hot Sheet
Price: $15.50 --0%
Financial Fact:
Basic and diluted net loss per share: -0.9
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Basic and diluted net loss per share: -0.9
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Dynavax (NASDAQ: DVAX) reported Q4 EPS of $0.45, $0.04 better than the analyst estimate of $0.41. Revenue for the quarter came in at $184.5 million versus the consensus estimate of $179.6 million.
For earnings history and earnings-related data on Dynavax (DVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
